Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways

Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration

(2023) Massimo Mapelli et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?

(2022) Massimo Mapelli et al.   Frontiers in Cardiovascular Medicine

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2021) Theresa A McDonagh et al.   EUROPEAN HEART JOURNAL

Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan

(2021) Valentina Mantegazza et al.   Diagnostics

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan

(2019) Peder Langeland Myhre et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

(2019) Michael R. Zile et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

(2019) Orly Vardeny et al.   EUROPEAN JOURNAL OF HEART FAILURE

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure

(2018) Eric J. Velazquez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

(2016) Autores/Miembros del Grupo de Trabajo: Piotr Ponikowski et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

(2013) John J. V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

(2012) Scott D Solomon et al.   LANCET